| pubmed-article:16084176 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16084176 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16084176 | lifeskim:mentions | umls-concept:C0022658 | lld:lifeskim |
| pubmed-article:16084176 | lifeskim:mentions | umls-concept:C0360714 | lld:lifeskim |
| pubmed-article:16084176 | lifeskim:mentions | umls-concept:C1948041 | lld:lifeskim |
| pubmed-article:16084176 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:16084176 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
| pubmed-article:16084176 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:16084176 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:16084176 | pubmed:dateCreated | 2005-8-8 | lld:pubmed |
| pubmed-article:16084176 | pubmed:abstractText | We sought to examine whether statin therapy before percutaneous coronary intervention results in reduction in contrast-induced nephropathy (CIN). Intravascular administration of contrast media can have nephrotoxic effects, particularly in patients with baseline renal insufficiency. Along with lowering serum cholesterol, statins have pleiotropic effects in the vasculature. The effect of statin use on CIN is unknown. | lld:pubmed |
| pubmed-article:16084176 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16084176 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16084176 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16084176 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16084176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16084176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16084176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16084176 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16084176 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:16084176 | pubmed:issn | 0002-9343 | lld:pubmed |
| pubmed-article:16084176 | pubmed:author | pubmed-author:SmithDean EDE | lld:pubmed |
| pubmed-article:16084176 | pubmed:author | pubmed-author:Kline-RogersE... | lld:pubmed |
| pubmed-article:16084176 | pubmed:author | pubmed-author:MoscucciMauro... | lld:pubmed |
| pubmed-article:16084176 | pubmed:author | pubmed-author:O'DonnellMich... | lld:pubmed |
| pubmed-article:16084176 | pubmed:author | pubmed-author:ShareDavidD | lld:pubmed |
| pubmed-article:16084176 | pubmed:author | pubmed-author:AttallahNizar... | lld:pubmed |
| pubmed-article:16084176 | pubmed:author | pubmed-author:KhanalSanjaya... | lld:pubmed |
| pubmed-article:16084176 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16084176 | pubmed:volume | 118 | lld:pubmed |
| pubmed-article:16084176 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16084176 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16084176 | pubmed:pagination | 843-9 | lld:pubmed |
| pubmed-article:16084176 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:meshHeading | pubmed-meshheading:16084176... | lld:pubmed |
| pubmed-article:16084176 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16084176 | pubmed:articleTitle | Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. | lld:pubmed |
| pubmed-article:16084176 | pubmed:affiliation | Henry Ford Heart and Vascular Institute, Henry Ford Hospital, Detroit, Mich 48202, USA. skhanal1@hfhs.org | lld:pubmed |
| pubmed-article:16084176 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16084176 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16084176 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16084176 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16084176 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16084176 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16084176 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16084176 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16084176 | lld:pubmed |
